Volume 3 Issue 2

Use of Liraglutide in a Tertiary Bariatric Clinic: A Case Series

Daniel Ta, Jerry T. Dang, Arya M. Sharma, Shahzeer Karmali and Renuca Modi
Liraglutide is a glucagon-like peptide-1 analogue approved for obesity management. In controlled clinical trials, high dose liraglutide (3.0 mg) has previously demonstrated efficacy and safety as a pharmacological option for weight loss in patients with obesity.

Read More